Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

Allergan, Inc. - SWOT Analysis

MarketLine, July 2011, Pages: 28


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Allergan, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Allergan, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Allergan is a multi-specialty health care company. It is engaged in the discovery, development and commercialization of innovative pharmaceuticals, biologics and medical devices. Allergan’s products address ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention and other specialty markets. The company is headquartered in Irvine, California and employed approximately 9,200 people as of December 31, 2010. The company recorded revenues of $4,919.4 million during the financial year (FY) ended December 2010, an increase of 9.2% over FY2009. The operating profit of the company was $258.6 million during FY2010, as compared with an operating profit of $928 million in FY2009. The net profit was $0.6 million in FY2010, as compared with a net profit of $621.3 million in FY2009. The significant decline in profits during FY2010 was mainly due to legal settlement and intangible asset impairment and related costs.

Scope of the Report

- Provides all the crucial information on Allergan, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Allergan, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Allergan, Inc.
-Data is supplemented with details on Allergan, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Allergan, Inc.

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds